Issue 11, 2016

Improved antiviral activity of a polyamide against high-risk human papillomavirus via N-terminal guanidinium substitution

Abstract

We report the synthesis of two novel pyrrole–imidazole polyamides with N-terminal guanidinium or tetramethylguanidinium groups and evaluate their antiviral activity against three cancer-causing human papillomavirus strains. Introduction of guanidinium improves antiviral activity when compared to an unsubstituted analog, especially in IC90 values. These substitutions change DNA-binding preferences, while binding affinity remains unchanged.

Graphical abstract: Improved antiviral activity of a polyamide against high-risk human papillomavirus via N-terminal guanidinium substitution

Supplementary files

Article information

Article type
Research Article
Submitted
05 Jul 2016
Accepted
04 Oct 2016
First published
05 Oct 2016

Med. Chem. Commun., 2016,7, 2076-2082

Author version available

Improved antiviral activity of a polyamide against high-risk human papillomavirus via N-terminal guanidinium substitution

C. H. Castaneda, M. J. Scuderi, T. G. Edwards, G. D. Harris Jr., C. M. Dupureur, K. J. Koeller, C. Fisher and J. K. Bashkin, Med. Chem. Commun., 2016, 7, 2076 DOI: 10.1039/C6MD00371K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements